Repligen Corp. (RGEN)
142.99
-0.59
(-0.41%)
USD |
NASDAQ |
Feb 10, 16:00
142.99
0.00 (0.00%)
After-Hours: 20:00
Repligen Price : 142.99 for Feb. 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Enovis Corp. | 22.59 |
| Abbott Laboratories | 112.33 |
| Accuray, Inc. | 0.553 |
| Alphatec Holdings, Inc. | 13.90 |
| Plus Therapeutics, Inc. | 0.2645 |
Price Related Metrics
| PE Ratio | 5542.25 |
| PS Ratio | 11.40 |
| Price to Book Value | 3.864 |
| Price to Free Cash Flow | 77.96 |
| Earnings Yield | 0.02% |
| Market Cap | 8.049B |
| Operating PE Ratio | 172.66 |
| Normalized PE Ratio | 238.16 |